Cue Health granted $13 million federal government contract to develop portable, point-of-care COVID-19 test

by RJ Shara | Mar 31, 2020 | Startups

Biotech start-up Cue Health has protected a $13 million contract from the U.S. Department of Health and Human Service’s Biomedical Advanced Research study and Advancement Authority (BARDA), which will be used to speed the development and screening of a handheld molecular test that can spot the presence of the SARS-CoV-2 novel coronavirus that causes COVID-19. Hint, […] The startup received a previous $30 million contract from BARDA in 2018, which was allocated for the development and recognition of an over-the-counter diagnostic test for influenza and multiplex breathing pathogens.”We have actually worked with the BARDA group for the previous two years developing and checking a 20-minute, molecular influenza test designed for home and point-of-care use,” stated Cue Health CEO Ayub Khattak in a statement. …